CIK: 0001839435 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value ($000): $718,655 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | 2,618,300 | $238,527 | 33.2% | $48.31 | +78.6% | COM | 03753U106 |
| — | VERONA PHARMA PLC | 2,468,000 | $52,174 | 7.3% | $17.59 | — | SPONSORED ADS | 925050106 |
| — | CYMABAY THERAPEUTICS INC | 4,570,918 | $50,052 | 7.0% | $7.72 | — | COM | 23257D103 |
| RCUS | ARCUS BIOSCIENCES INC | 1,968,000 | $39,970 | 5.6% | $33.27 | -42.8% | COM | 03969F109 |
| ROIV | ROIVANT SCIENCES LTD | 3,904,000 | $39,352 | 5.5% | $8.23 | +8.6% | SHS | G76279101 |
| — | MIRATI THERAPEUTICS INC | 750,000 | $27,098 | 3.8% | $52.54 | — | COM | 60468T105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 759,898 | $25,783 | 3.6% | $25.60 | +31.7% | COM NEW | 15117B202 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 923,000 | $21,958 | 3.1% | $25.79 | -0.5% | COM | 92790C104 |
| BBIO | BRIDGEBIO PHARMA INC | 1,219,200 | $20,970 | 2.9% | $30.51 | -50.7% | COM | 10806X102 |
| — | 89BIO INC | 1,066,784 | $20,216 | 2.8% | $16.66 | — | COM | 282559103 |
| IRON | DISC MEDICINE INC | 415,000 | $18,426 | 2.6% | $35.48 | 0.0% | COM | 254604101 |
| VIR | VIR BIOTECHNOLOGY INC | 650,100 | $15,947 | 2.2% | $25.11 | 0.0% | COM | 92764N102 |
| — | RENEO PHARMACEUTICALS INC | 2,368,587 | $15,538 | 2.2% | $6.46 | — | COM | 75974E103 |
| TNDM | TANDEM DIABETES CARE INC | 474,929 | $11,655 | 1.6% | $54.82 | -41.3% | COM NEW | 875372203 |
| — | AEROVATE THERAPEUTICS INC | 621,712 | $10,662 | 1.5% | $29.30 | — | COM | 008064107 |
| — | ITEOS THERAPEUTICS INC | 596,000 | $7,891 | 1.1% | $18.03 | — | COM | 46565G104 |
| DYN | DYNE THERAPEUTICS INC | 692,945 | $7,796 | 1.1% | $12.99 | -9.2% | COM | 26818M108 |
| INSM | INSMED INC | 367,000 | $7,744 | 1.1% | $18.97 | 0.0% | COM PAR $.01 | 457669307 |
| — | ALPINE IMMUNE SCIENCES INC | 750,000 | $7,710 | 1.1% | $7.20 | — | COM | 02083G100 |
| TVTX | TRAVERE THERAPEUTICS INC | 495,000 | $7,603 | 1.1% | $21.26 | -14.4% | COM | 89422G107 |
| GERN | GERON CORP | 2,278,000 | $7,312 | 1.0% | $2.84 | +0.2% | COM | 374163103 |
| XLO | XILIO THERAPEUTICS INC | 2,425,000 | $6,354 | 0.9% | $2.77 | +9.5% | COM | 98422T100 |
| ANTX | AN2 THERAPEUTICS INC | 720,900 | $6,128 | 0.9% | $7.19 | 0.0% | COM | 037326105 |
| — | JASPER THERAPEUTICS INC | 4,468,114 | $6,121 | 0.9% | $1.81 | — | COM | 471871103 |
| VKTX | VIKING THERAPEUTICS INC | 375,000 | $6,079 | 0.8% | $4.46 | +369.3% | COM | 92686J106 |
| ANNX | ANNEXON INC | 1,660,000 | $5,843 | 0.8% | $5.18 | -15.6% | COM | 03589W102 |
| — | GLYCOMIMETICS INC | 3,000,000 | $5,220 | 0.7% | $1.26 | — | COM | 38000Q102 |
| GOSS | GOSSAMER BIO INC | 3,958,069 | $4,750 | 0.7% | $5.38 | -76.8% | COM | 38341P102 |
| LXRX | LEXICON PHARMACEUTICALS INC | 1,923,076 | $4,404 | 0.6% | $2.65 | 0.0% | COM NEW | 528872302 |
| GPCR | STRUCTURE THERAPEUTICS INC | 75,000 | $3,118 | 0.4% | $23.79 | — | SPONSORED ADS | 86366E106 |
| PMVP | PMV PHARMACEUTICALS INC | 470,000 | $2,942 | 0.4% | $5.24 | 0.0% | COM | 69353Y103 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 411,928 | $2,550 | 0.4% | $3.94 | — | SPONSORED ADS | 152309100 |
| ORIC | ORIC PHARMACEUTICALS INC | 277,000 | $2,150 | 0.3% | $5.68 | 0.0% | COM | 68622P109 |
| STOK | STOKE THERAPEUTICS INC | 185,669 | $1,974 | 0.3% | $27.91 | -61.9% | COM | 86150R107 |
| — | IVERIC BIO INC | 50,000 | $1,967 | 0.3% | — | — | Put | 46583P102 |
| — | HEPION PHARMACEUTICALS INC | 155,000 | $1,628 | 0.2% | $10.50 | — | COM NEW | 426897302 |
| VERA | VERA THERAPEUTICS INC | 70,000 | $1,124 | 0.2% | $14.69 | -38.5% | CL A | 92337R101 |
| — | PIERIS PHARMACEUTICALS INC | 6,600,000 | $1,092 | 0.2% | $0.20 | — | COM | 720795103 |
| — | MAGENTA THERAPEUTICS INC | 550,000 | $417 | 0.1% | $0.76 | — | COM | 55910K108 |
| — | INOZYME PHARMA INC | 49,702 | $277 | 0.0% | $5.57 | — | COM | 45790W108 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 19,900 | $136 | 0.0% | $6.47 | 0.0% | COM | 61225M102 |